Rituximab-associated hypogammaglobulinaemia in ANCA-associated vasculitis and connective tissue diseases: a longitudinal observational study.

CONCLUSIONS: Hypogammaglobulinaemia following RTX is uncommon in AAV and CTD and is more likely in patients with high glucocorticoids and cyclophosphamide exposure and low IgG levels at baseline.
PMID: 32441645 [PubMed - as supplied by publisher]

Source: Clinical and Experimental Rheumatology - May 23, 2020 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research